Biotech Startup Cellogen Therapeutics Raises ₹20 Cr from Kotak Alts
Biotech startup Cellogen Therapeutics has secured ₹20 Cr (about $2 Mn) in funding from Kotak Alternate Asset Managers (Kotak Alts).
18 May 10:05 · Inc42
Biotech Startup Cellogen Therapeutics Raises ₹20 Cr from Kotak Alts
Biotech startup Cellogen Therapeutics has secured ₹20 Cr (about $2 Mn) in funding from Kotak Alternate Asset Managers (Kotak Alts).
18 May 10:05 · Inc42
last updated on 18 May 21:05